OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation
Mark R. Schmitt, Fatih Ceteci, J. R. P. Gupta, et al.
Nature (2022) Vol. 612, Iss. 7939, pp. 347-353
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Drug-tolerant persister cells in cancer: the cutting edges and future directions
Yi Pu, Lu Li, Haoning Peng, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 799-813
Closed Access | Times Cited: 62

Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses
Henner F. Farin, Mohammed H. Mosa, Benardina Ndreshkjana, et al.
Cancer Discovery (2023) Vol. 13, Iss. 10, pp. 2192-2211
Open Access | Times Cited: 53

Naphtho[1,2-b][1,4]diazepinedione-Based P2X4 Receptor Antagonists from Structure–Activity Relationship Studies toward PET Tracer Development
Katharina Sophie Erlitz, Ann‐Kathrin Prinz, Stefan Wagner, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 2

Artesunate ameliorates irinotecan-induced intestinal injury by suppressing cellular senescence and significantly enhances anti-tumor activity
Hui Jie Jia, Shi-rui Bai, Jing Xia, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110205-110205
Closed Access | Times Cited: 26

Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective
Tania B. López-Méndez, Miguel Sánchez‐Álvarez, Flavia Trionfetti, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25

Different Roles of Apoptosis and Autophagy in the Development of Human Colorectal Cancer
Giulia Orlandi, Luca Roncucci, Gianluca Carnevale, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10201-10201
Open Access | Times Cited: 25

The role of organoids in cancer research
Zhen Fang, Peijuan Li, Fengying Du, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 23

CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer
Chunge Zhong, Wenjie Jiang, Yingjia Yao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12

Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
Mariangela Russo, Mengnuo Chen, Elisa Mariella, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 694-717
Closed Access | Times Cited: 12

Activation of fetal-like molecular programs during regeneration in the intestine and beyond
Sara Viragova, Dong Li, Ophir D Klein
Cell stem cell (2024) Vol. 31, Iss. 7, pp. 949-960
Closed Access | Times Cited: 9

“Find Me” and “Eat Me” signals: tools to drive phagocytic processes for modulating antitumor immunity
Lingjun Xiao, Louqian Zhang, Ciliang Guo, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 791-832
Open Access | Times Cited: 8

Spermidine – an old molecule with a new age-defying immune function
Kenji Chamoto, Baihao Zhang, Masaki Tajima, et al.
Trends in Cell Biology (2023) Vol. 34, Iss. 5, pp. 363-370
Open Access | Times Cited: 19

Let’s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment
Mobina Bayat, Javid Sadri Nahand
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 7

Death and survival from executioner caspase activation
Gongping Sun
Seminars in Cell and Developmental Biology (2023) Vol. 156, pp. 66-73
Closed Access | Times Cited: 14

DAMPs in immunosenescence and cancer
Fangquan Chen, Hu Tang, Xiutao Cai, et al.
Seminars in Cancer Biology (2024) Vol. 106-107, pp. 123-142
Closed Access | Times Cited: 5

Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/Akt signaling pathway
Ningning Yao, Qingyue Ma, Wendan Yi, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 4

Terahertz Wave Desensitizes Ferroptosis by Inhibiting the Binding of Ferric Ions to the Transferrin
Xiangji Li, Yangmei Li, Junxuan Xu, et al.
ACS Nano (2025)
Closed Access

Microbes, macrophages, and melanin: a unifying theory of disease as exemplified by cancer
Stacie Z. Berg, Jonathan Berg
Frontiers in Immunology (2025) Vol. 15
Open Access

Chloroquine Enhances Chemosensitivity of Breast Cancer via mTOR Inhibition
Zhuo Lin, Yuting Xu, Mifang Li, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 948-948
Open Access

An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer
Kai Zhao, Yan Yu, Xiao‐Kang Jin, et al.
Nature Nanotechnology (2025)
Closed Access

P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer
Stephan Ledderose, Severin Rodler, Lennert Eismann, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2321-2321
Open Access | Times Cited: 9

Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models
Christofer Rupert, Carmela Dell’ Aversana, Laura Mosca, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 9

Page 1 - Next Page

Scroll to top